Dr. Dapeng Li
Assistant Professor
Center for Infectious Disease Research
School of Medicine
Westlake University
biography
Dr. Dapeng Li received his bachelor’s degree in Veterinary Medicine from Nanjing Agricultural University in 2010, and got his PhD in Microbiology from Institut Pasteur of Shanghai, Chinese Academy of Sciences in 2016. He was then trained at Duke Human Vaccine Institute, Duke University School of Medicine as a postdoctoral associate and a research scientist from 2017 to 2021, under the mentorship of Dr. Barton Haynes. He served as an Instructor in Medicine at the Department of Medicine, Duke University School of Medicine from 2021 to 2022. Dr. Li joined Westlake University in 2022 as an assistant professor and Principal Investigator of the Laboratory of Vaccinology and Immunotherapy.
The Dapeng Li Laboratory focuses on vaccine design, with a particular emphasis on vector-borne viruses from the Flaviviridae and Bunyavirales that pose significant public health challenges. Our research integrates advanced methodologies from immunology and virology, as well as cutting-edge technologies such as single-cell omics, systems biology, structural biology, protein design, and molecular/cellular fate mapping.
Title
Identification of Ultrapotent Neutralizing Epitopes for Vector-Borne Bunyaviruses
abstract
Emerging bunyaviruses, such as severe fever with thrombocytopenia syndrome virus (SFTSV) and hantaviruses, cause life-threatening diseases with high mortality, yet lack approved antiviral therapies. Defining conserved, vulnerable neutralizing epitopes is essential for developing effective countermeasures. Here, we report the identification and structural characterization of ultrapotent neutralizing epitopes across bunyavirus surface glycoproteins. For SFTSV, we discovered ZS1C5, a human antibody targeting a novel interdomain epitope on glycoprotein Gn with subnanomolar potency. A single dose of ZS1C5 conferred robust protection in mice and non-human primates, with repertoire mining revealing germline-encoded precursors. For hantaviruses, cryo-EM analysis defined two non-overlapping conserved sites: an apical Gn–Gc interface and a basal Gc domain II region. Guided by these structures, we engineered a dual-epitope bispecific antibody that broadly neutralizes Old and New World hantaviruses and provides post-exposure in vivo protection. Together, these findings reveal key neutralization vulnerabilities, providing blueprints for next-generation therapeutics and vaccines against emerging bunyaviruses.
